tiprankstipranks
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market
4886
ASKA Pharmaceutical Holdings Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4886 full AI Analyst Report?

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Income Statement

0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Income Statement

Last quarter (Q1 2025), ASKA Pharmaceutical Holdings Co., Ltd.'s total revenue was ¥17.64B, an increase of 7.88% from the same quarter last year. In Q1, ASKA Pharmaceutical Holdings Co., Ltd.'s net income was ¥1.25B. See ASKA Pharmaceutical Holdings Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 71.13B¥ 64.14B¥ 62.84B¥ 60.46B¥ 56.61B
Gross Profit
¥ 34.15B¥ 31.34B¥ 30.66B¥ 28.59B¥ 26.35B
Operating Expenses
¥ 28.31B¥ 26.00B¥ 24.16B¥ 23.48B¥ 21.56B
Depreciation and Amortization
¥ 0.00¥ 2.25B¥ 2.66B¥ 3.13B¥ 2.88B
EBITDA
¥ 5.83B¥ 7.58B¥ 9.16B¥ 8.24B¥ 7.68B
Operating Income
¥ 5.83B¥ 5.33B¥ 6.50B¥ 5.11B¥ 4.80B
Other Income/Expenses
¥ 1.16B¥ 859.00M¥ 3.36B¥ 248.00M¥ 1.37B
Pretax Income
¥ 6.99B¥ 6.19B¥ 9.86B¥ 5.36B¥ 6.16B
Net Income
¥ 5.42B¥ 5.10B¥ 7.54B¥ 4.24B¥ 4.29B
Per Share Metrics
Basic EPS
¥ 191.10¥ 179.95¥ 266.49¥ 150.08¥ 151.22
Diluted EPS
¥ 191.10¥ 179.95¥ 266.49¥ 150.08¥ 151.22
Weighted Average Shares Outstanding
 28.38M 28.35M 28.31M 28.24M 28.37M
Weighted Average Shares Outstanding (Diluted)
 28.38M 28.35M 28.31M 28.24M 28.37M
Currency in JPY

ASKA Pharmaceutical Holdings Co., Ltd. Earnings and Revenue History